Top 5 Dow Dividend Companies To Buy For 2015

The Organization of Petroleum Exporting Companies (OPEC) has lost its mojo. Actually, it�� been disappearing for years and most people are just beginning to notice. The cartel has not controlled crude oil prices for at least the last seven or eight years and its position is deteriorating fast.

Last week�� meeting of OPEC ministers concluded with the unsurprising decision to maintain the cartel�� official production quota of 30 million barrels a day. Iran, though, was very clear that it plans to boost production well above its current level of 2.8 million barrels a day, targeting 4 million barrels a day by the end of next year.

The Saudis are now in the position either of supporting a rise in the quota — and the concomitant drop in prices — or cutting its own production to accommodate Iranian plans. But the Saudis can only do that for so long; the country�� economy is built on oil exports and any long-term cut to production raises serious problems for the princes who run the Kingdom.

Top 5 Dow Dividend Companies To Buy For 2015: Carter's Inc.(CRI)

Carter's, Inc., together with its subsidiaries, designs, sources, and markets branded children?s wear. The company provides products under the Carter?s, Child of Mine, Just One You, Precious Firsts, OshKosh, and related brand names. Its Carter?s brand baby products include bodysuits, pants, undershirts, towels, washcloths, receiving blankets, layette gowns, bibs, caps, and booties; playclothes products consist of knit and woven cotton apparel; sleepwear products comprise pajamas and blanket sleepers; and other products consist of bedding, outerwear, swimwear, shoes, socks, diaper bags, gift sets, toys, and hair accessories. The company also provides playclothes products, including denim apparel products, overalls, woven bottoms, knit tops, and playclothes products for sizes newborn to 12 under the OshKosh brand. In addition, it offers baby, sleepwear, outerwear, shoes, hosiery, and accessories under the OshKosh brand. The company sells its products in department stores, national chains, and specialty retailers, as well as through its Carter?s and OshKosh retail stores; and online at carters.com and oshkoshbgosh.com. As of December 31, 2011, it operated 359 Carter?s and 170 OshKosh outlet and brand retail stores in the United States; and 65 retail stores in Canada. The company was founded in 1865 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By AnnaLisa Kraft]

  Carter's (NYSE: CRI  ) , the branded marketer of baby and children's wear, is facing the headwinds of declining birthrates in the US and Canada. In the US, the crude birth rate (births per 1,000 people) has declined to levels not seen since the Great Depression: down 7% plus since 2007.Worldwide, the crude birth rate is expected to decline from the early 1950's 37.2 births to 13.4.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Carter's (NYSE: CRI  ) , whose recent revenue and earnings are plotted below.

Top 5 Dow Dividend Companies To Buy For 2015: Sangamo BioSciences Inc.(SGMO)

Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off; and ZFP nucleases (ZFNs), proteins that enable to modify DNA sequences in various ways. The company?s principal ZFP therapeutic include SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene that is in a Phase 2b clinical trial for the treatment of severe diabetic neuropathy; and in a Phase 2 clinical trial in for the treatment of amyotrophic lateral sclerosis, as well as in preclinical animal studies for spinal cord injury, traumatic brain injury, and stroke. It is also developing SB-728-T, a ZFN-modified T-cell product, which is in Phase 1/2 clinical trial and two Phase 1 trials for the treatment of HI V/AIDS. In addition, the company develops SB-313xTZ, a ZFN-based therapeutic that is in Phase 1 clinical trial for the treatment of glioblastoma multiforme, a type of brain cancer. Further, it has preclinical development programs of ZFP therapeutics in the areas of Parkinson?s disease, hemophilia B, and neuropathic pain; and neuroregenerative programs in spinal cord injury, traumatic brain injury, and stroke. Additionally, the company has research stage programs in the areas of monogenic diseases and genetic conditions that result from a defect in a single gene, including hemophilia and other hemoglobinopathies, and immunodeficiencies. It has collaboration agreements with Sigma-Aldrich Corporation; Dow AgroSciences LLC; Pfizer Inc.; Genentech, Inc.; Open Monoclonal Technology, Inc.; and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. The company was founded in 1995 and is headquartered in Richmond, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Sangamo Biosciences (NASDAQ: SGMO) shot up 29.01 percent to $17.61 after the company and Biogen Idec (NASDAQ: BIIB) announced the global collaboration to develop treatments for hemoglobinopathies.

• [By Sean Williams]

  What: Shares of Sangamo Biosciences (NASDAQ: SGMO  ) , a clinical stage biopharmaceutical company focused on developing zinc finger DNA-binding proteins, rose as much as 11% after the company reported its first-quarter results.

• [By MONEYMORNING]

  That's not always the case. I watched as one well-known blogger on The Street sabotaged Antares Pharma (Nasdaq: ATRS) right after FDA approval for a new rheumatoid arthritis delivery system a few months ago, and it's taken a long time for ATRS to finally recover. A similar thing happened to Sangamo Biosciences (Nasdaq: SGMO), which stopped my subscribers out of the stock. I advised them to buy right back into it, and we currently just exited with a 73.4% return on it.

• [By John McCamant, Editor, Medical Technology Stock Letter]

  The company-Sangamo (SGMO)-expects that TALE architectures to be broadly adopted and become the industry standard.

  When combined with Sangamo's proprietary engineered ZFP technology, or DNA cutting domains, the TALE technology can be harnessed to efficiently and precisely edit gene sequences.

Top 5 Prefered Companies To Buy For 2015: Potomac Electric Power Company(POM)

Pepco Holdings, Inc., through its subsidiaries, engages in the transmission, distribution, and supply of electricity. The company also distributes and supplies natural gas. It distributes electricity to approximately 1.8 million customers in the mid-Atlantic region and delivers natural gas to approximately 123,000 customers in Delaware. In addition, the company involves in the retail supply of electricity and natural gas; provision of energy efficiency services to federal, state, and local government customers; and designs, constructs, and operates combined heat and power and central energy plants, as well as owns and operates two oil-fired generation facilities. Further, it offers high voltage electric construction and maintenance services, low voltage electric construction and maintenance services, and streetlight construction and asset management services to utilities, municipalities, and other customers in the Washington, District of Columbia. Additionally, the company holds investments in eight cross-border energy leases. Pepco Holdings, Inc. was founded in 1896 and is based in Washington, District of Columbia.

Advisors' Opinion:

• [By Ben Levisohn]

  Exelon�shares have been no doubt strong year-to-date, but we think the improvement in underlying business fundamentals is far from reflected in the share price, particularly after the pullback around equity to fund Pepco (POM).

Top 5 Dow Dividend Companies To Buy For 2015: Japan Petroleum Exploration Co Ltd (JPTXF)

Japan Petroleum Exploration Co., Ltd. is a company principally involved in the energy business. The Company operates in four geological segments. The Japan segment involves in the production, purchase and sale of crude oil and natural gas in Japan, the contracting of drilling and refurbishment works, mud logging works, research works, geophysical exploration works, the provision of pipeline maintenance services and security guard services, the purchase and sale of petroleum products, the transportation of petroleum and natural gas products, as well as real estate management business. The North America segment involves in the exploration and development of crude oil and natural gas in North America. The Middle East segment involves in the development of crude oil and natural gas. The Others segment involves in the exploration, development and production of crude oil and natural gas in Southeast Asia. As of March 31, 2013, the Company had 26 subsidiaries and 17 associated companies. Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)

Top 5 Dow Dividend Companies To Buy For 2015: iGATE Corporation(IGTE)

iGATE Corporation provides outsourced information technology (IT) and IT-enabled operations solutions and services worldwide. The company offers various services that include development and maintenance of software application; implementation and support of enterprise applications; package evaluation and implementation; re-engineering; data warehousing; business intelligence; analytics; data management and integration; software testing; IT infrastructure management; business and technology consulting; and enterprise software and systems integration, as well as quality assurance services and product engineering services. It also provides business process outsourcing, transaction processing, and customer interaction services. The company serves various industries, including insurance and healthcare, manufacturing, retail and logistics, banking and financial services, communications and utilities, media and entertainment, life sciences, and product engineering. It has India, Canada, the United States, Europe, Mexico, Singapore, Malaysia, Japan, Australia, the United Arab Emirates, South Africa, Turkey, South Korea, China, Switzerland, and the United Kingdom. iGATE Corporation was founded in 1996 and is headquartered in Fremont, California.

Advisors' Opinion:

• [By Seth Jayson]

  iGATE (Nasdaq: IGTE  ) reported earnings on April 11. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), iGATE beat slightly on revenues and crushed expectations on earnings per share.